CBAY - Cymabay Therapeutics Inc
IEX Last Trade
12.4
0.260 2.097%
Share volume: 1,338,346
Last Updated: Tue 08 Aug 2023 09:59:57 PM CEST
Pharmaceutical Preparation Manufacturing :
-2.88%
PREVIOUS CLOSE
CHG
CHG%
$12.14
0.26
2.14%
Summary score
37%
Profitability
43%
Dept financing
3%
Liquidity
45%
Performance
37%
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
Long-term ratios 30-Jun-2016 - 30-Jun-2020
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-51.52%
Return on assets
-13.27%
Return on sales
-61.53%
Return on invested capital
130.17%
Total debt ratio
25.25%
Debt ratio change over timeo
-0.67%
Current Ratio
10.58%
Quick Ratio
0%
Cash Position Ratio
3.07%
Short-term ratios 30-Jun-2019 - 30-Jun-2020
The data are presented for the financials results of the quarters of the last year.
Return on equity
-10.53%
Return on assets
-9.53%
Return on sales
0%
Return on invested capital
172.56%
Total debt ratio
7.78%
Debt ratio change over timeo
-0.96%
Current Ratio
14.65%
Quick Ratio
0%
Cash Position Ratio
4.7%
Last quarter ratios 30-Jun-2020
The data are presented for the financials results of the last quarter.
Return on equity
-6.48%
Return on assets
-6.42%
Return on sales
0%
Return on invested capital
153.6%
Total debt ratio
6.22%
Debt ratio change over time
-0.96%
Current Ratio
18.37%
Quick Ratio
0%
Cash Position Ratio
10.13%
Performance ratios (change over 4 years) 30-Jun-2016 - 30-Jun-2020
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-177.07%
Return on assets
-115.16%
Return on sales
-175.05%
Return on invested capital
12.6%
Total debt ratio
-67.12%
Debt ratio change over time
-0.67%
Current Ratio
8.63%
Quick Ratio
0%
Cash Position Ratio
1.81%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | CBAY | VLON | ELAT | RETA |
|---|---|---|---|---|
| Return on equity | -51.52% | 0% | 0% | 29.06% |
| Return on assets | -13.27% | 0% | 0% | -9.75% |
| Return on sales | -61.53% | 0% | 0% | -1469.44% |
| Return on invested capital | 130.17% | 0% | 0% | 47.78% |
| Profitability | 25% | 0% | 50% | 34% |
| Total debt ratio | 25.25% | 0% | 0% | 183.15% |
| Debt ratio change over time | -0.67% | 0% | 0% | 19.02% |
| Dept financing | 3% | 0% | 0% | 50% |
| Current Ratio | 14.65% | 0% | 0% | 5.9% |
| Quick Ratio | 0% | 0% | 0% | 5.9% |
| Cash Position Ratio | 4.7% | 0% | 0% | 5.68% |
| Liquididy | 45% | 0% | 0% | 59% |
| Short-term ratios | CBAY | VLON | ELAT | RETA |
|---|---|---|---|---|
| Return on equity | -10.53% | 0% | 0% | -16.12% |
| Return on assets | -9.53% | 0% | 0% | -14.95% |
| Return on sales | 0% | 0% | 0% | -3498.94% |
| Return on invested capital | 172.56% | 0% | 0% | 96.56% |
| Profitability | 50% | 0% | 50% | 14% |
| Total debt ratio | 7.78% | 0% | 0% | 79.61% |
| Debt ratio change over time | -0.96% | 0% | 0% | 0.09% |
| Dept financing | 2% | 0% | 0% | 50% |
| Current Ratio | 14.65% | 0% | 0% | 5.9% |
| Quick Ratio | 0% | 0% | 0% | 5.9% |
| Cash Position Ratio | 4.7% | 0% | 0% | 5.68% |
| Liquididy | 46% | 0% | 0% | 60% |